Measurement Technology in Downstream Processing Market Outlook 2031
The global measurement technology in downstream processing market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of XX% during 2023–2031. The market growth is attributed to the prevalence of chronic illnesses and rising demand for wireless continuous measurement technologies.
Increasing preference for biopharmaceuticals, due to their high efficiency and fewer side effects, and growing investment in the development of biologics, which is expected to boost the market. The rising prevalence of chronic diseases including cancer, cardiovascular diseases, and diabetes is driving the demand for biologics. Downstream processing is essential for the isolation and purification of biochemical products, which is expected to boost the demand for measurement technologies in the market during the forecast period.
-
On May 24, 2023, ElevateBio, LLC, a technology-driven firm focused on the development of life-transforming cells & gene therapies, announced the closing of its USD 401 million Series D financing round. This investment is estimated to advance the company’s cells and gene technology, therapeutic pipeline, and end-to-end capabilities.
Precise measurement of substance purification in downstream processes is essential. Growing advances in measurement technologies are propelling their demand in the healthcare, pharmaceutical, and food & beverages sectors. Advanced measurement technologies are making the isolation of bioproducts highly efficient and accurate. Growth of the biopharmaceutical industry and the adoption of measurement technologies to the development of biologics, is likely to create opportunities in the market.
The research report finds that the COVID-19 pandemic slightly affected the measurement technology in the downstream processing market. During the initial days of the pandemic, supply chain disruptions and operation slowdowns led to a decline in the market. However, the focus on developing COVID-19 vaccine and diagnostics solutions helped in the recovery. Expanding digitization in the healthcare and pharmaceutical industries, post the normalization of the pandemic, which is further supporting the demand for measurement technologies.
Impact of Artificial Intelligence (AI) on Measurement Technology in Downstream Processing Market
Advancement in AI is anticipated to increase growth potential of the companies in the market. AI with advanced sensors, is likely to empower end-users with self-adaptive systems. It has the scope to enhance monitoring in healthcare and pharmaceutical research to make it precise and well-organized. The demand for AI and machine learning (ML) solutions is rising for bioprocess development and research. This is likely to increase the use of AI-powered solutions for downstream processing measurement in the coming years.
Measurement Technology in Downstream Processing Market Dynamics
Major Drivers
Increasing demand for biopharmaceuticals is expected to propel the market during the forecast period. For bioprocessing, real-time measurement technologies during downstream processes are vital, as they enable improved process understanding for further optimization. Biopharmaceutical drugs are highly performing and cost-efficient, which results in their high demand for chronic illnesses such as diabetes, cancer, and cardiovascular diseases.
-
According to information published by the National Institute of Health (NIH) in December 2022, biopharmaceuticals played a major role in the global healthcare industry since the emergence of the COVID-19 pandemic. Several biopharma solutions including COVID-19 vaccines and therapeutics were quickly developed during this period. In the US and the EU, about 197 biologics received approval and 180 distinct active biopharmaceutical ingredients entered the market between January 2018 and June 2022.
High prevalence of chronic diseases is driving the demand for biologics, which is expected to propel the market. As downstream processing is a key requirement for the separation and purification of bio components, their demand is growing in bioprocessing to develop various biological medical products. This consequently drives the demand for measurement technologies such as biomedical temperature sensors for improved monitoring of biosynthetics.
Existing Restraints
High failure rate of conventional sensors in larger applications is expected to hamper the market. In several instances, measurement sensors including electrochemical probes had a higher failure. The limited applicability of conventional sensors is likely to affect their demand in the market. Additionally, the lack of a skilled workforce and the high cost required for measurement technologies are likely to hinder the growth of the market in the coming years.
Emerging Opportunities
Growing advances in measurement technologies and rising demand for quality measurements in biologics development are expected to generate new opportunities in the market. Precise measurement enables the creation of efficient biologics, for which real-time monitoring of bioprocesses is required. Advanced sensors and measurement systems are getting preference over conventional measurement solutions in the pharmaceutical industry. This, as a result, has opened up opportunities for companies in the market to develop innovative measurement solutions for fulfilling these demands.
Scope of the Measurement Technology in Downstream Processing Market Report
The global market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Measurement Technology in Downstream Processing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product (Sensors [pH Sensors, DO Sensors, Cell Density Sensors, and Conductivity Sensors], Cables & Connectors, Transmitters & Controllers, Sensor Housings, and Buffers & Reagents), Modality (Reusable and Single-use), and End-user (Food & Beverage Companies, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Contract Manufacturing Organizations, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Broadley-James Corporation; Endress+Hauser Group Services AG; Evoqua Water Technologies LLC; Getinge; Hamilton Company; METTLER TOLEDO; m-oem; optek-Danulat GmbH; PendoTECH; PreSens Precision Sensing GmbH; Sartorius AG; Sensorex; Thermo Fisher Scientific Inc.; Waters Corporation; and YSI Inc
|
Market Segment Insights
Product Analysis
Based on product, the measurement technology in downstream processing market is divided into Sensors, Cables & Connectors, Transmitters & Controllers, Sensor Housings, and Buffers & Reagents. The sensors segment is further classified as pH sensors, DO sensors, cell density sensors, and conductivity sensors. The sensors segment is projected to witness major growth in demand during the projection period, owing to increasing preference for advanced biomedical sensors. These are specially designed electronic devices that convert biomedical signals to conveniently measurable electric signals.
Modern standard operating procedures (SOPs) demand continuous feedback sensors for deriving precise results. These sensors provide acute feedback and process control to record parameters in bioprocesses such as temperature, DO (Dissolved Oxygen), pH, and other necessary attributes. These factors, coupled with growing research and development activities in the healthcare and pharmaceutical industry, are likely to propel the segment.
Modality Analysis
On the basis of modality, the global market is bifurcated into reusable and single-use. The single-use segment is projected to register a considerable CAGR during the forecast period, due to its multiple advantages in step-by-step detection in various analytical systems. The single-use modality adoption is growing at a rapid pace in laboratories or bench scale, and at commercial establishments, owing to their limited possibility of cross-contamination and easy usability. These benefits of single-use modality are driving their demand on a global scale, thereby, driving the segment.
End-user Analysis
On the basis of end-user, the measurement technology in downstream processing market is segmented into food & beverage companies, pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, contract manufacturing organizations, and others. The pharmaceutical & biotechnology companies’ segment is expected to register a robust growth rate during the forecast period, owing to the growing focus on research & development for scaling up the new drug offerings.
Increasing prevalence of various types of cancer, chronic kidney diseases (CKD), and diabetes further fuels the need for safe and efficient drugs. As a result, biopharmaceuticals are highly demanded due to their efficacy against these diseases. This is likely to propel demand for bioprocess technology solutions in the coming years.
-
On May 26, 2023, the World Health Organization (WHO) and the Republic of Korea signed a Memorandum of Understanding (MoU) to establish a world-class biomanufacturing training hub. This center is intended to serve global low and middle-income countries (LMICs) to manufacture biologicals. The MoU is likely to expand the development of biopharmaceuticals including vaccines, monoclonal antibodies, insulin, and cancer drugs.
Regional Outlook
In terms of region, the global measurement technology in downstream processing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is anticipated to dominate the market during the projection period, due to increasing investment in the development of biological medical products.
Major economies in this region, such as India and China, are focusing on the local development of biopharmaceuticals. These drugs are highly demanded, due to their proven efficacy against life-threatening health conditions. The availability of a qualified workforce at a reasonable budget further supports the growth of the biopharma industry in this region. These factors are likely to propel the demand for measurement technologies for the development of bio-drugs.
The market in North America is expected to grow at a rapid pace during the forecast period, owing to the rising adoption of automation technologies in bioprocessing systems. Increasing focus on scaling up R&D for innovation of new drugs is likely to further expand opportunities for the companies in the market. Integration of technological advancements in bioprocess systems is giving rise to the launch of advanced measurement solutions such as biomedical temperature sensors. Furthermore, the presence of several key players is anticipated to further fuel the market in this region.
Segments
The global Measurement Technology in Downstream Processing Market has been segmented on the basis of
Product
- Sensors
- pH Sensors
- DO Sensors
- Cell Density Sensors
- Conductivity Sensors
- Cables & Connectors
- Transmitters & Controllers
- Sensor Housings
- Buffers & Reagents
Modality
End-user
- Food & Beverage Companies
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
- Contract Manufacturing Organizations
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Broadley-James Corporation
- Endress+Hauser Group Services AG
- Evoqua Water Technologies LLC
- Getinge
- Hamilton Company
- METTLER TOLEDO
- m-oem
- optek-Danulat GmbH
- PendoTECH
- PreSens Precision Sensing GmbH
- Sartorius AG
- Sensorex
- Thermo Fisher Scientific Inc.
- Waters Corporation
- YSI Inc
Competitive Landscape
Key players competing in the Measurement Technology in Downstream Processing Market are Broadley-James Corporation; Endress+Hauser Group Services AG; Evoqua Water Technologies LLC; Getinge; Hamilton Company; METTLER TOLEDO; m-oem; optek-Danulat GmbH; PendoTECH; PreSens Precision Sensing GmbH; Sartorius AG; Sensorex; Thermo Fisher Scientific Inc.; Waters Corporation; and YSI Inc.
These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide. The competitive landscape covers key insights into growth strategies adopted by major market players.
-
In August 2023, Endress Houser, a Swiss-based worldwide process operating and laboratory instrumentation & automation supplier, opened a new production facility in Aurangabad, India. This modern production unit is intended to manufacture temperature measurement technologies and system products as well as liquid analysis solutions.
-
In May 2020, Hamilton Company announced its process analytics sensors unit’s transition to a direct sales model, covering most of the market in the US and Canada. This transition is applicable to all the major US-based biotech hubs. including Raleigh-Durham, Boston/Cambridge, and the San Francisco Bay area.
Request For Customization
Enquiry Before Buying
Speak With Analyst
